Allergan and Pfizer: Botox and Viagra Makers Merge

Allergan and Pfizer: Botox and Viagra Makers Merge

Monday, November 23 2015 | 00 h 00 min | Latest News

Biopharma giants Pfizer Inc. and Allergan plc announced unanimous board approval for the merger of the two companies, in a transaction value of $160 billion US. Under the agreement, Allergan shares are valued at a 30% premium as of the October 28 share price.

The combined company will operate under the Pfizer umbrella. The announcement touts the addition of growing revenue streams from Allergan’s portfolio, including Aesthetics and Dermatology, Eye Care and other therapeutic categories.

Read the full press release:

http://www.premierbiopharmaleader.com/en/media/press-releases/pfizer-and-allergan-to-combine/

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Vision Expo 2026 Launches “Call for NEW” to Spotlight Industry Innovation

Vision Expo 2026 launches its Call for NEW initiative, spotlighting product debuts, technologies and innovations ahead of the unified annual event in Orlando.

Learn More

EssilorLuxottica Joins Forces with Fondazione Chips-IT to Accelerate the Future of Smart Eyewear

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate smart-eyewear innovation through next-generation chip design, open-hardware collaboration and advanced wearable technologies.

J.F. Rey Unveils New Women’s Collection Showcasing Exceptional Craftsmanship and Mastery of Colour

J.F. Rey launches its new Women’s Collection with 11 shapes and 55 colours, showcasing exceptional craftsmanship, bold design and masterful colour innovation.

opti 2026 Unveils TOMORROW VISION and opti SPHEARE: New Platforms for Contact Lens Innovation and Hearing Care

opti 2026 is spotlighting two major growth drivers: TOMORROW VISION, a high-energy innovation platform for contact lenses, and opti SPHEARE, a new experiential centre for hearing care.

EssilorLuxottica Introduces Essilor® Stellest® 2.0 Lenses to Canada, Advancing Childhood Myopia Management

EssilorLuxottica has introduced Essilor® Stellest® 2.0 lenses in Canada, offering stronger efficacy and enhanced design features for childhood myopia management.

Allergan and Pfizer: Botox and Viagra Makers Merge

Featured Posts